-
5 Facts About Canadian Prime Minister Mark Carney: From Bitcoin To Hockey
Monday, March 10, 2025 - 2:51pm | 1241Read More...Canada is expected to have a new prime minister with former central banker Mark Carney winning the country's Liberal Party election to replace outgoing Prime Minster Justin Trudeau, who announced his intention to step down in January. Carney has had a fast rise in Canadian politics but also enters...
-
Oxford Researchers Say Roche's Arthritis Drug Cuts Death In Hospitalized COVID-19 Patients
Thursday, February 11, 2021 - 12:53pm | 195Read More...Oxford researchers have reportedly found that Roche Holdings AG’s (OTCMKT: RHHBY) arthritis drug Actemra (tocilizumab), when combined with the steroid dexamethasone, cuts the risk of death among patients hospitalized with severe COVID-19, as well as shorten the time to...
-
AstraZeneca COVID-19 Vaccine Triggers Robust Immune Response In Older Adults, Peer-Reviewed Study Says
Thursday, November 19, 2020 - 5:10am | 460Read More...British pharmaceutical giant AstraZeneca plc's (NASDAQ: AZN) COVID-19 vaccine developed in collaboration with the University of Oxford is safe and triggers a similar immune response among all adults, as per the preliminary findings of a peer-reviewed phase two trial, CNBC reports...
-
Participant In AstraZeneca, Oxford University COVID-19 Vaccine Trial Dies
Wednesday, October 21, 2020 - 4:00pm | 281Read More...Brazilian newspaper O Globo reported that a participant in a Phase 3 trial for a COVID-19 vaccine has died. What Happened: The Brazilian Health Authority Anvisa said testing will continue. Anvisa was notified Oct. 19 of the death. Related Link: AstraZeneca Could Resume US Covid-...
-
AstraZeneca Trial Participant Adverse Events Likely Unrelated To COVID-19 Vaccine: Oxford
Wednesday, September 16, 2020 - 9:49pm | 385Read More...AstraZeneca Plc’s (NYSE: AZN) vaccine didn't likely cause the adverse events that suspended the late-stage human trials of the drug, according to Oxford University. What Happened: Volunteers in the British drugmaker’s ChAdOx1 nCoV-19 vaccine trial developed unexplained neurological...
-
Moderna Faces Hurdle With Coronavirus Vaccine As Court Refuses To Invalidate Arbutus Patent
Friday, July 24, 2020 - 12:02am | 472Read More...Moderna Inc (NASDAQ: MRNA) has lost the bid to invalidate a key patent related to the development of several of its next-generation vaccines, including one meant for coronavirus, to Arbutus Biopharma Corp (NASDAQ: ABUS), Reuters reported. What Happened The Massachusetts-headquartered company...
-
AstraZeneca Strikes Deal With Four EU Countries Over 400M Coronavirus Vaccine Doses
Monday, June 15, 2020 - 8:32am | 327Read More...AstraZeneca plc (NYSE: AZN) on Saturday said it had reached an agreement with Europe's Inclusive Vaccines Alliance (IVA) to supply 400 million doses of its novel coronavirus (COVID-19) vaccines by the end of the year. What Happened The IVA is a group of four countries, Germany, France, the...
-
Oxford University Coronavirus Vaccine Clinical Trial To Start Thursday With $24.6M Government Funding
Wednesday, April 22, 2020 - 5:46am | 435Read More...The clinical trials of a novel coronavirus (COVID-19) vaccine developed at Oxford University will start on Thursday, the United Kingdom Secretary of State for Health and Social Care Matt Hancock revealed Tuesday. What Happened The U.K. government is funding the measure with $24.6 million (GBP 20...
-
Ledbury Makes A Splash In Wall Street Fashion
Thursday, May 30, 2013 - 8:59am | 365Read More...What makes a great fitting shirt? Ask the founders of Ledbury, who have recently made waves in the high-end clothing market. The two appeared on CNBC's Squawk Box to talk about their shirts, blazers, ties, and accessories, ranging from where they come from to what makes them special. Paul...
-
Nassim Talib: Ron Paul, The Only Candidate Addressing Structural Issues
Tuesday, March 13, 2012 - 11:47am | 326Read More...Nassim Taleb, the best-selling author of The Black Swan, endorsed the presidential aspirations of Ron Paul. "From the risk vantage point, Paul is the only candidate that represents my values," he told CNBC earlier today. "There are four key issues that no one else is addressing," said NYU...









